A best evidence topic in surgery was written according to a structured protocol. The question addressed was in patients with oesophago-gastric junctional tumours which have been radiologically-staged as potentially resectable, is diagnostic laparoscopy useful as an additional staging procedure. 292 papers were found using the reported search, of which 5 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group, study type, relevant outcomes and results of these papers are tabulated. We conclude that as an additional tool following radiological staging of oesophago-gastric junctional tumours, diagnostic laparoscopy does appear to detect previously occult peritoneal metastases as well as liver metastases and lymph nodes and these findings do in turn lead to changes in management in over ten percent of patients. The procedure is however associated with some morbidity and its efficacy in changing management in the era of routine PET scanning remains to be evaluated.
Introduction
A best evidence topic was constructed according to a structured protocol as described in a previous publication. 1 
Clinical scenario
You are at a multi-disciplinary team meeting discussing a patient with a biopsy-proven oesophago-gastric junctional (OGJ) tumour. He has undergone computed tomography (CT) of the chest and abdomen and endoscopic ultrasound (EUS) which have staged him as a T3N1M0 adenocarcinoma. He is physiological fit for oesophagectomy however it is suggested that he undergo diagnostic laparoscopy prior to consideration for resection. You resolve to check the literature to ascertain whether diagnostic laparoscopy after radiological staging of OGJ tumours adds useful staging information prior to resection?
Three-part question
In patients with radiologically-staged resectable disease undergoing an oesophagectomy for an OGJ tumour, does laparoscopy provide useful additional staging information?
Search strategy
Medline 1966 to January 2011 using the OVID interface for the terms:
[
staging] AND [laparoscopy] AND [oesophago-gastric] OR [oesophageal] AND [cancer].

Search outcome
292 abstracts were found using the reported search. Using the criteria outlined in a previous publication, 1 we selected only those papers which to directly assess the impact of laparoscopy on staging and operative management. This yielded five papers which provided the best evidence to answer the clinical question.
Results
The results of the five papers that provided the best evidence to answer the question are summarised in Table 1 .
Discussion
Despite improvements in the management of oesophageal cancer long-term survival following surgical resection remains poor. Part of the reason for this lies in the fact that many of the patients undergoing resection have occult advanced disease at the This study uses a bi-modal minimally-invasive approach to surgical staging. With reference to the findings on laparoscopy alone, it demonstrates the value in DL as far as re-staging cancers and discusses the usefulness of visualising the peritoneum directly in the detection of metastases.
The study does not specify the site at which the unexpected lymph nodes were found The paper also discusses the relative sensitivities and specificities of thoracoscopy and laparoscopy.
time of surgery. As a consequence of this there has been increased focus on accurate pre-operative staging of oesophageal cancers to detect non-regional lymph node involvement, peritoneal disease and distant metastases in order to prevent futile surgery on patients with non-surgically curable disease. Over the last twenty years there has been increasing use of CT and EUS as routine preoperative staging modalities for oesophageal cancer. 2 Diagnostic laparoscopy (DL) is a well-established procedure in its own right for staging a number of intra-abdominal cancers and has been shown to be useful in detecting lymphadenopathy, peritoneal and liver metastases. 3 With respect to the efficacy of DL as an adjuvant staging therapy following radiological staging of tumours, the earliest study was performed by Bonavina et al. 6 who analysed a cohort of patients with distal oesophageal and gastric cardia tumours who had been staged radiologically using CT and ultrasound. These patients underwent a staging laparoscopy and if this was clear proceeded to oesophagectomy at the same sitting. In this study, DL changed the treatment plan in 10% of patients. In addition to evaluating the role of DL as an adjunct to radiological staging, this study also looked at DL in isolation and concluded it was a more sensitive staging test than either CT or US. It should be noted however that the study did not compare DL against the combined information obtained from both CT and US and as such does not comment on the relative efficacy of DL as compared to the synergistic information from all radiological scanning. Romijn et al. 7 conducted a study in which biopsy-proven oesophageal or gastric cardia cancer patients who had been radiologically staged using ultrasound, CT and EUS underwent DL together with laparoscopic ultrasonography (LUS). DL resulted in a change in management in 13% of their population-in all cases due to the detection of peritoneal or liver metastases. This study did not evaluate the role of DL in the detection of occult lymph node involvement; instead preferring to use LUS for this purpose. Interestingly they found that LUS was useful in the detection of occult coeliac lymph node involvement. Their overall conclusion was that DL is of little benefit in oesophageal carcinoma but had more of a role in the staging of gastric cardia tumours. Heath et al. 5 performed a small retrospective study on patients with biopsy-proven oesophageal cancers, all of whom had undergone staging using CT and EUS. This study demonstrated that DL led to a change in treatment in 17% of their population. In the majority this was due to laparoscopy detecting serosal spread into the stomach, necessitating a change in operative strategy as opposed to changes in oncological stage-however 7% of patients had occult peritoneal or liver metastases detected by DL alone. In addition Heath et al 2 utilised DL to attempt to perform routine lymph node biopsies although this was only technically achievable in 75% of cases. This strategy of lymph node biopsy did but did lead to changes in the status of regional lymph nodes but did not lead to any change in management of the cancers. With respect to the operative procedure itself, the mean hospital stay was 2 days and there were significant complications in 2 patients. The authors did however note that DL could be used a therapeutic procedure to insert a feeding jejenostomy in the cases where the tumours were discovered to be unresectable. Krasna et al. 8 examined 111 patients with pathologically proven oesophageal cancer; all of whom had been pre-operatively radiologically staged using CT and USS and in some cases EUS and MRI. These patients then underwent minimally-invasive staging using combined thoracoscopy and laparoscopy (in 67 patients), thoracoscopy alone (in 35 patients) or laparoscopy alone (in 9 patients). With respect to the 76 patients who underwent DL, this procedure resulted in upstaging in 21 patients-the majority being due to the diagnosis of previously occult coeliac lymph node involvement. Although this paper does not specifically differentiate between changes in management made as a result of thoracoscopy or laparoscopy it does appear from analysing the data that DL led to changes in management in 24% of cases. They also concluded that DL itself has a higher sensitivity and specificity for the detection of lymph node involvement as compared to combined radiological staging. Although the study has a large number of patients it should be noted that the cohort was heterogeneous with regard to histological cell type and as previously discussed there was no uniform radiological staging for all patients. The largest and most recent study on this topic was undertaken by de Graaf et al. 4 This retrospective study was conducted on 416 patients with oesophago-gastric cancer who were staged preoperatively based on CT and/or EUS or abdominal ultrasound. Diagnostic laparoscopy resulted in changes to staging 21% of the patients with 20% becoming non-operable mainly due to the diagnosis of previously undetected peritoneal carcinomatosis. It should be noted however that although this was a large-scale study, patients did not undergo standardised radiological staging and this study failed to distinguish between oesophageal, junctional and gastric tumours, choosing instead to treat them as a single cohort. In addition, there is a paucity of information on the exact findings on laparoscopy-for example 17 patients were deemed unresectable due to the presence of "locally advanced disease" but there is not information as to exactly what this term entailed. On reviewing all of these studies, it is striking that there are that no randomised-controlled trials on the role of DL and most of the studies involved relatively small populations with significant heterogeneity with regard to the tumour location and the radiological techniques used to stage the cancers. In addition, the majority of these studies are include patients operated over a decade ago and as such pre-date the publication of the MRC study 9 on the efficacy of pre-operative chemotherapy and the introduction of routine positron emission tomography (PET) as a staging modality. Given the documented efficacy of this radiological tool in detecting occult disseminated disease, 10 it is unclear, in the era of routine neoadjuvant chemotherapy and PET, whether the finding that DL provides useful additional staging information is still applicable. Finally it should be noted that although the addition of DL does appear to be superior to radiological imaging alone in detecting occult disseminated disease, it is still associated in these studies with a false negative rate of approximately 5%.
Clinical bottom line
As an additional staging tool following radiological staging of OGJ tumours, diagnostic laparoscopy does appear to detect previously occult peritoneal metastases as well as liver metastases and lymph nodes. These findings in turn lead to changes in management in over ten percent of patients. The procedure is however associated with some morbidity and its efficacy in changing management in the era of routine PET scanning remains to be evaluated.
